Guy Y. Krippner
75 Commercial Rd
Melbourne, VIC 8008, Australia
Melbourne, VIC 8008, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CD14 Blockade Modulates Macrophage-Mediated Immunological Injury in a Translational Model of Reperfused ST-Segment Elevation Myocardial Infarction.
Journal: JACC. Basic to translational science
Published: February 21, 2025
A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein.
Journal: EMBO molecular medicine
Published: April 29, 2022
Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases.
Journal: Pharmacology & therapeutics
Published: January 27, 2022
Pharmacokinetic study of the novel phosphocholine derivative 3-dibutylaminopropylphosphonic acid by LC-MS coupling.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: March 24, 2021
Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.
Journal: Frontiers in immunology
Published: October 24, 2020
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.
Journal: Journal of medicinal chemistry
Published: May 01, 2019
Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy.
Journal: Diabetes
Published: June 28, 2018
Treatment of type 2 diabetes with the designer cytokine IC7Fc.
Journal: Nature
Published: May 15, 2018
A versatile approach for the site-specific modification of recombinant antibodies using a combination of enzyme-mediated bioconjugation and click chemistry.
Journal: Angewandte Chemie (International ed. in English)
Published: November 28, 2014
Efficacy and safety of oral methazolamide in patients with type 2 diabetes: a 24-week, placebo-controlled, double-blind study.
Journal: Diabetes care
Published: August 16, 2014
The structure of vanin 1: a key enzyme linking metabolic disease and inflammation.
Journal: Acta crystallographica. Section D, Biological crystallography
Published: July 16, 2014
The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice.
Journal: PloS one
Published: December 19, 2012
Last Updated: 09/26/2026